CloneID	GO	UACC383	KA	UACC3093	UACC2534	M92-001	A-375	UACC502	M91-054	UACC1256	UACC091	UACC1273	M93-007	HA-A	MCF10A	UACC1012	SRS3	TC-MA	UACC1022	TD-1720	TD-1638	TD-1730	TC-1376-3	TD-1376-3	TC-HA	SRS5	RMS13	CRC1634	Nil.C	UACC1529	UACC827	WM1791C	UACC647	UACC3149	UACC1097	UACC903	UACC2837	M93-047	UACC930	TITLE
20115	GO:0015385	0.75	1.04	0.99	1.37	1.1	1.06	0.94	0.85	1.13	1.09	1.67	1.91	0.93	0.76	0.75	0.89	1.07	1.28	0.86	1.59	1.36	0.99	1.01	1.29	1.3	1.12	1.09	1.53	0.74	1.09	1.18	1.2	1.97	1.75	0.46	1.81	1.12	1.01	Human mRNA for KIAA0267 gene, partial cds
21420	GO:0003924GO:0008047	1.01	0.73	0.81	0.9	1.36	1.05	1.86	1.21	1.52	1.05	1.39	1.4	0.5	0.59	1.03	0.9	0.71	1.21	1.1	0.87	0.74	0.84	0.96	0.88	0.87	1.02	0.97	1.25	1.28	1.1	1.22	0.84	0.84	2.73	1.31	1.05	1.03	1.95	Human nucleotide binding protein mRNA, complete cds
21468	GO:0004393	0.61	0.59	0.7	1.78	0.76	0.84	0.74	1.31	0.71	1.07	1.03	0.85	0.71	0.63	0.78	0.78	0.77	0.92	0.61	0.73	0.87	0.8	9.74	0.95	0.81	1.42	1.08	1.64	0.7	0.61	1.46	0.66	1.22	1.39	1.02	0.72	0.73	1.06	Homo sapiens heparan N-deacetylase/N-sulfotransferase-2 mRNA, complete cds
21477	GO:0004725GO:0005001	1.33	1.92	1.05	1.19	1.35	1.18	0.83	1.37	1.93	1.14	1.02	1.53	1.58	1	1.05	0.88	1.41	1.27	1.53	1.96	1.32	1.14	1.64	1.3	1.08	1.07	1.29	1.45	1.42	1.13	0.92	1.06	0.95	2.84	0.71	1.29	1.27	2.16	Protein tyrosine phosphatase, receptor type, alpha polypeptide
21531	GO:0005096GO:0005516	0.21	0.28	0.45	0.36	2.57	0.34	0.64	0.56	3.01	0.44	0.45	1.15	0.24	0.45	0.3	0.78	0.53	2.17	2.14	1.6	7.54	3.27	3.68	0.66	2.06	0.4	0.92	1.32	0.83	0.45	1.31	5.32	5.6	1.07	0.95	0.45	0.8	1.4	REGULATOR OF G-PROTEIN SIGNALLING 2
21652	GO:0005194	1.21	0.89	0.63	0.71	1.21	0.59	1.04	0.73	0.7	0.45	0.87	0.63	1.27	1.4	1.39	1.06	0.26	0.27	0.45	0.52	0.55	0.68	0.49	0.58	1.55	0.9	0.98	0.63	0.86	1.35	0.82	0.8	0.82	0.51	1.23	0.96	1.04	0.82	Catenin (cadherin-associated protein), alpha 1 (102kD)
21652	GO:0005194	0.89	0.76	0.53	0.75	1.16	0.48	1.07	0.91	0.72	0.41	0.72	0.59	0.94	1.47	1.21	1.56	0.29	0.39	0.54	0.48	0.83	0.9	0.5	0.91	1.68	0.83	0.92	0.64	0.85	1.16	0.9	0.98	0.94	0.67	1.21	0.91	0.74	0.81	Catenin (cadherin-associated protein), alpha 1 (102kD)
21656	GO:0005515GO:0003713GO:0016251	0.78	1.2	0.93	1.05	0.89	1.24	1.01	0.69	1.02	1.71	1.17	0.9	1.45	0.67	1.13	0.82	0.83	0.46	0.65	0.91	0.45	1.84	1.66	1.34	1.23	1.51	1.7	4.67	0.78	0.89	0.73	0.98	0.97	0.92	0.78	0.71	1.14	0.86	ESTs, Highly similar to transcription factor IID [H.sapiens]
21738	GO:0005200	0.95	1.94	1.37	0.72	1.08	0.92	1.37	1.16	1.04	1.29	1.5	1.58	0.59	1.21	1.18	1.02	1.85	1.5	5.07	1.83	0.74	1.19	1.92	2.3	1.21	2.48	0.89	1.37	0.82	0.81	1.16	1.62	2.33	1.19	0.99	1.26	1.07	1.09	H.sapiens mRNA for L-3-hydroxyacyl-CoA dehydrogenase
21810	GO:0003677GO:0003950	0.29	2.74	0.9	0.57	0.53	0.63	0.76	0.74	0.52	0.6	0.9	0.66	0.89	0.43	0.78	1.26	1.15	0.58	1.2	0.85	0.33	0.98	0.76	1.05	0.97	1.47	0.6	1.52	0.6	0.64	0.34	0.61	0.69	0.54	0.73	1.2	0.63	0.87	ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)
22012	GO:0003924GO:0005525	0.7	0.93	0.43	1.55	0.91	1.47	0.85	0.32	0.86	1.13	0.54	0.99	0.46	2.27	0.7	0.41	0.33	0.9	0.6	1.68	1.62	0.48	0.69	0.56	0.71	1.84	1.06	0.83	0.9	2.11	1.24	1.15	1.31	1.79	0.77	1.56	2.33	0.85	ADP-ribosylation factor 3
22012	GO:0003924GO:0005525	0.43	1.16	0.26	1.71	0.95	1.45	1.11	0.79	0.91	1.2	0.83	1.03	0.43	3.08	0.81	0.9	0.45	1.07	0.64	1.83	0.74	0.57	0.54	0.65	0.97	1.28	1.57	2.07	1.36	2.14	1	1.19	1.43	2.42	1.27	1.66	2.48	0.89	ADP-ribosylation factor 3
22036	GO:0005057GO:0000264GO:0000263	0.78	1.11	0.54	1.07	0.93	1.65	1.33	0.86	0.8	1.26	0.65	1.28	0.78	0.38	0.66	0.69	0.71	0.54	0.43	0.38	0.74	1.29	0.71	1.46	0.83	2.11	1.3	2.25	0.64	0.74	0.83	0.56	0.88	1.91	1.09	1.45	0.85	1.23	Guanine nucleotide binding protein (G protein), alpha z polypeptide
22040	GO:0008133GO:0008270	0.61	1.28	1.35	1.43	1.32	0.81	0.95	1	1.4	1.53	1.36	1.09	0.83	1.18	1.1	1.05	0.96	2.38	0.83	1.14	1.16	1.81	1.24	1.57	1.21	1.91	3.2	1.62	0.91	1.53	1.55	1.03	1.88	1.45	1.35	1.85	1.07	1.08	matrix metalloproteinase 9 (gelatinase B, 92kD gelatinase, 92kD type IV collagenase)
22074	GO:0003700GO:0004887	0.99	0.45	1.29	1.12	0.39	1.9	1.21	0.89	1.18	1.49	1.79	1.24	0.7	1	1.07	0.32	0.77	0.83	0.34	0.86	0.74	1.39	2.33	1.06	1.3	0.76	1.49	1.66	0.63	1.04	1.23	1.3	2.12	1.6	1.01	1.43	0.91	1.24	thyroid hormone receptor, alpha (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog)
22230	GO:0005202	0.5	0.89	0.84	0.78	0.82	0.83	1.01	0.72	0.39	0.57	0.88	0.58	0.63	0.81	1.28	0.93	1.12	0.8	1.2	0.72	1.29	0.7	1.21	0.83	0.93	1.15	0.96	1.01	0.61	0.56	0.59	0.78	0.83	1.05	0.62	1.12	0.64	0.91	Collagen, type V, alpha 1
22260	GO:0009461	0.83	0.71	0.79	0.75	1.08	1.47	1.31	0.91	0.79	0.88	0.92	1.2	1.94	0.99	0.87	0.1	0.71	0.59	0.6	0.91	0.74	0.92	0.59	0.69	0.81	1.42	0.77	0.64	0.86	0.87	1.17	1.02	0.89	0.67	0.58	0.73	1.47	0.62	Cytochrome c1
22260	GO:0009461	1.01	1.25	0.74	0.87	1.44	0.66	0.92	0.77	1.33	0.77	0.84	1.73	0.5	2.24	0.79	0.96	0.71	5.41	0.76	0.87	0.74	2.61	0.96	2.63	1.31	1.11	1.27	1.4	1.93	1.58	1.57	1.29	1.53	1.81	1.28	0.87	1.37	1.58	Cytochrome c1
22285		1.87	1.25	2.88	1.12	4.7	2.06	2.1	3.74	2.11	1.1	1.13	2.47	1.27	0.55	1.49	1.74	1.62	4.35	3.37	5.03	2.92	6.24	8.02	2.13	2.24	0.69	1.72	1.64	1.92	0.48	4.82	1.59	1.45	1.8	2.21	0.57	1.19	1.32	ERYTHROCYTE BAND 7 INTEGRAL MEMBRANE PROTEIN
22293		1.01	0.73	0.82	1.71	1.08	0.92	1.21	1.53	1.42	0.95	1.14	1.16	0.96	0.92	1.03	0.9	0.71	1.21	1.1	0.87	0.74	0.84	0.96	1.18	0.87	0.98	0.75	1.38	0.88	0.91	0.74	0.84	1.24	2.07	1.01	0.91	0.9	1.04	no name
22293		0.87	0.76	0.85	1.56	0.76	0.97	0.64	0.51	1.23	1.15	1.15	1.01	0.59	0.67	0.69	0.83	1.35	1.35	0.47	1.05	0.99	1.13	1.02	0.81	0.86	1.05	0.77	0.83	0.81	0.6	0.7	0.9	0.99	1.05	0.62	0.98	0.82	0.96	no name
22379	GO:0005557	1.09	1.68	1.25	1.68	1.38	1.2	1.11	1.27	1.29	0.44	0.82	0.45	2.55	3.98	1.67	1.7	2.22	2	1.28	4.52	3.59	2.9	2.17	2.84	2.15	0.29	1.49	0.79	2.65	1.53	1.09	1.31	1.66	2.68	1.2	0.8	1.02	0.61	CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344)
22493	GO:0003723GO:0003735	1.23	2.3	1.34	1.76	0.9	0.93	1.15	0.97	1.4	0.71	0.93	0.82	1.2	0.78	0.99	1.15	1.35	1.14	0.65	0.87	1.01	2.13	2.42	1.61	1.31	0.84	0.82	0.69	0.93	0.85	0.44	0.74	0.92	1.12	1.21	0.91	1.02	1.01	ESTs, Weakly similar to F49C12.13 [C.elegans]
22493	GO:0003723GO:0003735	1.82	2.36	1.32	2.31	1.06	1.2	1.51	1.05	1.95	1.12	1.23	1.93	1.75	0.85	0.77	0.59	1.09	0.92	1.12	0.59	0.69	2.24	3.13	0.86	0.9	0.94	0.99	0.81	0.68	0.81	0.82	0.82	0.65	0.99	0.73	0.86	1.45	1.19	ESTs, Weakly similar to F49C12.13 [C.elegans]
22568	GO:0004674	0.8	1.23	0.89	0.96	0.7	1.02	0.73	0.65	1.15	1.44	1	0.74	0.93	1.03	1.1	1.07	0.53	0.92	1.38	1.16	0.68	0.82	0.68	1.11	1.58	1.69	0.85	1.33	0.77	0.89	1.08	1.05	1.27	1.5	1.4	0.83	1.64	1.43	H.sapiens ERK3 mRNA
22589		0.47	3.56	0.9	0.87	1.15	0.75	1.82	0.79	0.97	0.76	1.12	0.74	0.91	0.6	0.95	1.54	1.64	9.86	1.63	6.83	2.03	1.24	4.08	1.27	1.31	5.12	1.91	0.74	1.01	1.12	0.84	1.19	1.57	1.01	0.9	0.96	9.71	0.98	Human mRNA for KIAA0085 gene, partial cds
22589		0.66	1.7	1.03	1.05	1.6	1.16	2.4	0.8	0.67	0.91	1.12	0.92	0.95	0.89	0.99	1.11	0.71	20	2.6	10.6	6.93	1.77	9.68	1.28	1.57	4.15	1.95	0.76	0.96	1.14	0.98	2.15	2.02	1.22	0.93	0.86	4.81	0.94	Human mRNA for KIAA0085 gene, partial cds
22611	GO:0004644	1.15	1.22	1.12	1.32	1.08	0.81	1.14	1.35	0.94	1.29	0.81	0.93	1.19	0.39	1.22	1.44	1.53	0.92	0.71	0.81	0.74	2.06	1.09	0.99	1.34	1.61	1.05	0.99	2.88	2.52	1.41	1.14	0.98	0.86	1.81	0.93	0.9	1.53	ESTs
22711	GO:0004674	1.63	0.88	1.83	0.72	1.08	1.47	0.89	0.41	1.02	1.29	1.16	1.41	1.81	0.84	0.46	1.28	0.71	2.89	0.7	0.87	0.74	2.39	1.89	2.2	3.47	0.94	3.32	1.35	1.99	1.96	1.43	1.75	1.23	1.51	1.25	1.1	0.74	1.41	ESTs
22731	GO:0005198	18.71	9.72	14.25	6.89	4.08	5.34	3.36	2.25	3.68	1.36	1.99	1.71	7.45	0.8	1.16	13.61	10.87	5.15	12.74	16.01	17.85	10.33	20	8.47	14.95	0.96	0.91	0.3	15.08	2.62	1.15	1.46	1.15	3.34	1.43	0.55	0.67	0.62	proteolipid protein (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated)
22790	GO:0004872GO:0015025	0.48	0.68	0.69	0.84	1.17	0.46	0.63	0.87	0.9	0.64	0.62	0.98	0.61	0.72	1.15	1.14	0.71	1.38	0.55	0.76	0.74	1.81	1.22	1.21	1.29	1	1.06	0.97	2.5	0.98	1.69	1.29	1.56	1	1.18	0.77	1.6	1.91	Plasminogen activator, urokinase receptor